For Health Systems | Teal Health
Health Dept. Endorses At-Home Screening
Address health inequities, increase screenings, and save your providers time.
The Teal Wand will provide an improved experience - one that is preferred by 94% of women across all races, ethnicities, ages, income, and sexual and gender identity1 - while increasing your cervical cancer screening performance.
Book a Demo See How it Performs
Pilot Teal Health’s at-home screening to:
INCREASE HEDIS SCORE
Don’t let your patients fall behind. 94% of women prefer the Teal Wand to the current screening experience. Improve your screening rates and HEDIS score without spending more on resources.
SAVE TIME FOR PROVIDERS
With patients screening beforehand, at home, providers have more time to address additional patient needs and conduct other valuable tests.
ADDRESS HEALTH INEQUITIES
35-44 year olds, Hispanic, and Black women are impacted by cervical cancer at higher rates than most.2,3 With the Teal Wand, you can engage these populations in screening and follow-up care.
YOUR PATIENTS & PROVIDERS WILL THANK YOU
With the Teal Wand, you could see a nearly 20% increased screening rate across race and ethnicity.
1 in 4 U.S. women are not up-to-date on their cervical cancer screening.4 On average, 86% said they would stay up-to-date on screening if the Teal Wand was available.
DELIVER AN EXPERIENCE DESIGNED FOR WOMEN
Convenience and experience are important
Although consumers are generally inclined to stay with their current primary care provider, up to 70% are open to changing if the alternative offers meaningful differentiation.5
Of consumers reported being more satisfied with their recent telehealth appointment than with an in-person appointment.5
Of consumers take advantage of multimodal care: for example, nearly half of OBGYN telehealth visits are followed up with an in-person appointment.5
SELF-COLLECT CAN IMPROVE FOLLOW-UP ADHERENCE
Research shows self-collect leads to higher rates of follow-up care - as high as 85-94%6, compared to 50% today7
Teal Health for Health Systems
Let’s assemble a partnership that will satisfy your care measures and help you reach your goals.
Run a pilot program with underscreened patients
Women aged 35-44 years are most frequently diagnosed with cervical cancer. Moreover, Hispanic, Black, and Native American women are impacted at higher rates. That's over one third of the US female population. With the Teal Wand, you can engage more of these populations in routine screening and follow-up healthcare.
Refer patients for at-home screening
Whether we establish a larger screening program or handle screening requests individually, Teal Health has the infrastructure in place to ensure patients complete eligibility, receive their screening kit and their results, and have access to medical providers virtually.
Co-market on educational screening campaigns
Per a 2024 McKinsey report, "Consumers are most receptive to receiving information when learning about their health and managing their health at home."
How at-home screening works
- Kit is prescribed and shipped to the patient’s home. They collect a sample for HPV testing.
- Patient mails sample to lab and receive results in secure Teal account within a week.
- If needed, patient can connect virtually with a Teal provider and be referred to the health system for follow-up care.
Interested in a screening pilot?
Let’s work together to increase access and improve the cervical cancer screening experience
Backed by a rigorous clinical trial with the leading experts and organizations in healthcare
Ann S. Collins, MD, FACOG
OB/GYN
Centre Obstetrics and Gynecology
Christine Conageski, MD, MSc
OB/GYN and Associate Professor
Elizabeth Sutton PhD
Director of Scientific Research
Woman's Hospital
Ronald W. Orso, MD
OB/GYN
Birmingham Obstetrics & Gynecology, P.C.
Catherine Behrens, MD, PhD, FACOG
OB/GYN and Clinical Development Advisor
Emeline Aviki, MD, MBA
Medical Director, Network Integration and Strategy & Gynecologic Oncologist
Sangini S. Sheth, MD, MPH, FACOG
Associate Professor of Obstetrics, Gynecology & Reproductive Sciences